Unless stated otherwise, the following concentrations were applied: 5 M erastin, 1.13 M RSL3, 10 M FIN56, 10 M FINO2, 10 M sorafenib, 1 M Fer-1, 50 M DFO, and 1 M dexamethasone
We utilize leading liposome technology to encapsulate these substances in liposomes they can be protected until they reach the intestines, meaning that more of the active ingredient can make it into the bloodstream which is good for enhancing absorption and improving the bioavailability of glutathione molecules over 98%
Recent research studies have also shown that BPC-157 can counteract traumatic brain injuries, treat some central nervous system disorders, mitigate seizures, repair brain lesions, and reduce hypoglycemia side effects
Of the 34 patients enrolled, two withdrew before the start of treatment